Drug Company Payoffs:

Before heading home for a weeklong recess, the House of Representatives passed a bill on July 1 that would crack down on a devious tactic used by some pharmaceutical companies. The tactic, known as “pay for delay,” involves business deals in which the makers of patented brand-name drugs pay generic competitors to delay the introduction of cheaper alternatives.